Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation

Background Catestatin has been reported as a pleiotropic cardioprotective peptide. Heart failure with preserved ejection fraction (HFpEF) was considered a heterogeneous syndrome with a complex cause. We sought to investigate the role of catestatin in HFpEF and diastolic dysfunction. METHODS AND RESU...

Full description

Bibliographic Details
Main Authors: Zeping Qiu, Yingze Fan, Zhiyan Wang, Fanyi Huang, Zhuojin Li, Zhihong Sun, Sha Hua, Wei Jin, Yanjia Chen
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.029470
_version_ 1827942944866304000
author Zeping Qiu
Yingze Fan
Zhiyan Wang
Fanyi Huang
Zhuojin Li
Zhihong Sun
Sha Hua
Wei Jin
Yanjia Chen
author_facet Zeping Qiu
Yingze Fan
Zhiyan Wang
Fanyi Huang
Zhuojin Li
Zhihong Sun
Sha Hua
Wei Jin
Yanjia Chen
author_sort Zeping Qiu
collection DOAJ
description Background Catestatin has been reported as a pleiotropic cardioprotective peptide. Heart failure with preserved ejection fraction (HFpEF) was considered a heterogeneous syndrome with a complex cause. We sought to investigate the role of catestatin in HFpEF and diastolic dysfunction. METHODS AND RESULTS Administration of recombinant catestatin (1.5 mg/kg/d) improved diastolic dysfunction and left ventricular chamber stiffness in transverse aortic constriction mice with deoxycorticosterone acetate pellet implantation, as reflected by Doppler tissue imaging and pressure‐volume loop catheter. Less cardiac hypertrophy and myocardial fibrosis was observed, and transcriptomic analysis revealed downregulation of mitochondrial electron transport chain components after catestatin treatment. Catestatin reversed mitochondrial structural and respiratory chain component abnormality, decreased mitochondrial proton leak, and reactive oxygen species generation in myocardium. Excessive oxidative stress induced by Ru360 abolished catestatin treatment effects on HFpEF‐like cardiomyocytes in vitro, indicating the beneficial role of catestatin in HFpEF as a mitochondrial ETC modulator. The serum concentration of catestatin was tested among 81 patients with HFpEF and 76 non–heart failure controls. Compared with control subjects, serum catestatin concentration was higher in patients with HFpEF and positively correlated with E velocity to mitral annular e′ velocity ratio, indicating a feedback compensation role of catestatin in HFpEF. Conclusions Catestatin protects against diastolic dysfunction in HFpEF through attenuating mitochondrial electron transport chain–derived reactive oxygen species generation. Serum catestatin concentration is elevated in patients with HFpEF, probably as a relatively insufficient but self‐compensatory mechanism.
first_indexed 2024-03-13T10:07:15Z
format Article
id doaj.art-33037247dea041ba91d38110742ea346
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-13T10:07:15Z
publishDate 2023-05-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-33037247dea041ba91d38110742ea3462023-05-22T11:33:49ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-05-0112910.1161/JAHA.123.029470Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species GenerationZeping Qiu0Yingze Fan1Zhiyan Wang2Fanyi Huang3Zhuojin Li4Zhihong Sun5Sha Hua6Wei Jin7Yanjia Chen8Department of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaInstitute of Cardiovascular Diseases Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaDepartment of Cardiovascular Medicine, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai People’s Republic of ChinaBackground Catestatin has been reported as a pleiotropic cardioprotective peptide. Heart failure with preserved ejection fraction (HFpEF) was considered a heterogeneous syndrome with a complex cause. We sought to investigate the role of catestatin in HFpEF and diastolic dysfunction. METHODS AND RESULTS Administration of recombinant catestatin (1.5 mg/kg/d) improved diastolic dysfunction and left ventricular chamber stiffness in transverse aortic constriction mice with deoxycorticosterone acetate pellet implantation, as reflected by Doppler tissue imaging and pressure‐volume loop catheter. Less cardiac hypertrophy and myocardial fibrosis was observed, and transcriptomic analysis revealed downregulation of mitochondrial electron transport chain components after catestatin treatment. Catestatin reversed mitochondrial structural and respiratory chain component abnormality, decreased mitochondrial proton leak, and reactive oxygen species generation in myocardium. Excessive oxidative stress induced by Ru360 abolished catestatin treatment effects on HFpEF‐like cardiomyocytes in vitro, indicating the beneficial role of catestatin in HFpEF as a mitochondrial ETC modulator. The serum concentration of catestatin was tested among 81 patients with HFpEF and 76 non–heart failure controls. Compared with control subjects, serum catestatin concentration was higher in patients with HFpEF and positively correlated with E velocity to mitral annular e′ velocity ratio, indicating a feedback compensation role of catestatin in HFpEF. Conclusions Catestatin protects against diastolic dysfunction in HFpEF through attenuating mitochondrial electron transport chain–derived reactive oxygen species generation. Serum catestatin concentration is elevated in patients with HFpEF, probably as a relatively insufficient but self‐compensatory mechanism.https://www.ahajournals.org/doi/10.1161/JAHA.123.029470catestatindiastolic dysfunctionheart failure with preserved ejection fractionmitochondriareactive oxygen species
spellingShingle Zeping Qiu
Yingze Fan
Zhiyan Wang
Fanyi Huang
Zhuojin Li
Zhihong Sun
Sha Hua
Wei Jin
Yanjia Chen
Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
catestatin
diastolic dysfunction
heart failure with preserved ejection fraction
mitochondria
reactive oxygen species
title Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
title_full Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
title_fullStr Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
title_full_unstemmed Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
title_short Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation
title_sort catestatin protects against diastolic dysfunction by attenuating mitochondrial reactive oxygen species generation
topic catestatin
diastolic dysfunction
heart failure with preserved ejection fraction
mitochondria
reactive oxygen species
url https://www.ahajournals.org/doi/10.1161/JAHA.123.029470
work_keys_str_mv AT zepingqiu catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT yingzefan catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT zhiyanwang catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT fanyihuang catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT zhuojinli catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT zhihongsun catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT shahua catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT weijin catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration
AT yanjiachen catestatinprotectsagainstdiastolicdysfunctionbyattenuatingmitochondrialreactiveoxygenspeciesgeneration